SCHEMBL6404690

SCHEMBL6404690

CCOC(=O)CCSc1nnc(-c2cccnc2)[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.53
CYP3A4 P08684 2/20 0.53
CYP2C19 P33261 2/20 0.53
POLB P06746 5/20 0.49
LMNA P02545 3/20 0.49
KDM4E B2RXH2 4/20 0.45
ALDH1A1 P00352 4/20 0.45
HPGD P15428 3/20 0.45
HSD17B10 Q99714 3/20 0.45
RXFP1 Q9HBX9 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
NCOA1 Q15788 1/20 0.44
NCOA3 Q9Y6Q9 1/20 0.44
MMP2 P08253 1/20 0.42
MMP13 P45452 1/20 0.42
MMP14 P50281 1/20 0.42
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
MAPK1 P28482 2/20 0.41
MAPT P10636 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408678 0.80 CYP3A4 (0.40) CYP1A2CYP3A4CYP2C19POLBLMNA
SCHEMBL6407620 0.79 ALDH1A1 (0.48) CYP1A2CYP2C19POLBKDM4EALDH1A1
SCHEMBL29340379 0.76 TBXAS1 (0.50) CYP1A2CYP3A4CYP2C19POLBLMNA
SCHEMBL6411881 0.74 SMN1; SMN2 (0.56) CYP1A2CYP3A4CYP2C19POLBLMNA
SCHEMBL6405361 0.72 ALDH1A1 (0.56) LMNAKDM4EALDH1A1HPGDHSD17B10
SCHEMBL6408310 0.70 KMT2A (0.52) POLBLMNAKDM4EALDH1A1HPGD
SCHEMBL16907285 0.70 BTK (0.49) CYP1A2CYP3A4LMNAKDM4EALDH1A1
SCHEMBL10060497 0.70 KMT2A (0.66) POLBLMNAALDH1A1HPGDRXFP1
SCHEMBL13831073 0.70 MAPT (0.65) POLBALDH1A1HPGDRXFP1KMT2A
SCHEMBL6411295 0.69 MAPK14 (0.41) CYP1A2CYP3A4LMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT CYP1A2 93/4885CYP3A4 25/4885CYP2C19 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.